Haidan Chen

Dr Haidan Chen is an Associate Professor with Tenure at the Department of Medical Ethics and Law, School of Health Humanities, Peking University. Previously, she was a Research Fellow in the Science, Technology and Society Research Cluster at the Asia Research Institute (ARI), National University of Singapore (NUS). She has held various international visiting positions, including at the Institute for the Study of Science, Technology and Innovation (ISSTI), the University of Edinburgh; the Brocher Foundation in Switzerland; and as a Fulbright Visiting Scholar at the Centre for Biomedical Ethics, Stanford University.

Dr Chen’s research focuses on the ethical, legal, and social implications (ELSI) of genetics and genomics, and the governance of emerging medical technologies China—particularly stem cells, biobanks, precision medicine, neurotechnologies, and medical artificial intelligence. Her work has appeared in journals such as Science, Social Science & Medicine, BMC Medical Ethics, and Neuroethics. She serves on the Editorial Boards of BMC Medical Ethics and East Asian Science, Technology and Society: An International Journal.

Currently, she is an Academic Visitor at both the Uehiro Oxford Institute and the Centre for Health, Law and Emerging Technologies (HeLEX) at the University of Oxford. During her visit, her research investigates the ethical and social dimensions of utilizing emerging neurotechnologies for children with Attention Deficit Hyperactivity Disorder (ADHD) and patients with disorders of consciousness.